E. V. Goncharova

E. V. Goncharova

Auto-generated profile, based on publicly available information

E. V. Goncharova

Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2020 in Regional Anesthesia and Acute Pain Management
Verified
Journal Article
Open access
PDF file
EGE. V. Goncharova
E. V. Goncharova
APAlexey Polushin
Alexey Polushin
MKM. A. Kucher
M. A. Kucher
MEM. V. Ermolova
M. V. Ermolova
YZY. R. Zalyalov
Y. R. Zalyalov
ЗРЗалялов Ю. Р.
Залялов Ю. Р.
The article presents a clinical case of a 25-year-old patient with progressive diffuse B-cell lymphoma with lesions of the S2 nerve root, accompanied by pain syndrome that is not relieved by systemic multimodal analgesia using opioids, antiepileptic and non-steroidal anti-inflammatory drugs. Polyneuropathy, secondary immunodeficiency, thrombocytopenia grade IV refractory to platelet concentrate transfusion, Guillain-Barre syndrome, impaired the somatic status and intensified the pain syndrome. Local anesthetics epidural port was successfully implanted to improve quality of analgesia. As a result of prolonged epidural infusion of 0.2% ropivacaine with titration rate from 4 to 7 ml/hour depending on the severity of the pain syndrome, that significantly improved patients quality of life was achieved by reducing the intensity of pain and increasing duration of night sleep. In the early postoperative and long-term follow-up periods (14 days), there were no hemorrhagic and infectious complications associated with the use of the epidural port.

3 October 2022 in Russian neurological Journal
Verified
Journal Article
Closed access
PDF file
ISIa. B. Skiba
Ia. B. Skiba
SSSokolov Sokolov
Sokolov Sokolov
YVYu. S. Vaganova
Yu. S. Vaganova
EGE. V. Goncharova
E. V. Goncharova
APAlexey Polushin
Alexey Polushin
AKAlexander Kulagin
Alexander Kulagin
The aim of the study was to assess the incidence and clinical features of headache associated with the use of granulocyte colony-stimulating factor (G-CSF) for stem cell mobilization or neutropenia treatment among oncohematological patients and bone marrow donors.Material and methods. A prospective observational uncontrolled study included 39 participants: 20 bone marrow donors (group 1) and 19 oncohematological patients (group 2). We evaluated the incidence and clinical features of headache after subcutaneous administration of G-CSF (filgrastim) at doses of 5 to 10 μg/kg for 2 to 5 days.Results. Headache occurred in bone marrow donors more often compared to patients with hematological malignancies (78.9% vs 35.0%; p = 0.006). There were no significant differences in the time of headache onset, its duration, intensity, features, and localization between two groups. Gender, age, dose of G-CSF, and duration of its use were not associated with headache development in both groups.Conclusion. Headache occurs more often in bone marrow donors than in patients with hematological malignancies. The phenotype of headache associated with G-CSF exposure is not drug-specific and requires further studies on its semiotics.

15 July 2024 in Supportive Therapy in Oncology
Verified
Journal Article
Open access
PDF file
ASA. P. Spasova
A. P. Spasova
ADA. M. Dorozhenko
A. M. Dorozhenko
ARA. A. Ryazankina
A. A. Ryazankina
OBO. Yu. Barysheva
O. Yu. Barysheva
ABA. N. Burganova
A. N. Burganova
EGE. V. Goncharova
E. V. Goncharova
Neuropathic pain component occurs in every second patient with pain syndrome caused by a malignant tumor. Detection of the neuropathic component of pain syndrome is crucial for selection of effective analgesia.The review presents an application algorithm for an updated system of neuropathic pain component assessment in oncological patients.